))
China Just Approved A New Weight-Loss Drug, And American Utility Firms Are Powering Up On Infrastructure Spending
Manage episode 491829905 series 3598784
Content provided by Finimize. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Finimize or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
China just approved a local drugmaker’s weight-loss medicine, effectively ending Novo Nordisk and Eli Lilly’s two-horse race, while US utility firms are set to make record infrastructure investments – but Big Tech may still go entirely off-grid.
Today’s stories:
267 episodes
Share
